{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:41:05Z","timestamp":1793922065500,"version":"4.8.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A clinically important adverse drug reaction, heparin-induced thrombocytopenia (HIT), is induced by antibodies specific for complexes of the chemokine platelet factor 4 (PF4) and the polyanion heparin. Even heparin-naive patients can generate anti-PF4\/heparin IgG as early as day 4 of heparin treatment, suggesting preimmunization by antigens mimicking PF4\/heparin complexes. These antibodies probably result from bacterial infections, as (1) PF4 bound charge-dependently to various bacteria, (2) human heparin-induced anti-PF4\/heparin antibodies cross-reacted with PF4-coated Staphylococcus aureus and Escherichia coli, and (3) mice developed anti-PF4\/heparin antibodies during polymicrobial sepsis without heparin application. Thus, after binding to bacteria, the endogenous protein PF4 induces antibodies with specificity for PF4\/polyanion complexes. These can target a large variety of PF4-coated bacteria and enhance bacterial phagocytosis in vitro. The same antigenic epitopes are expressed when pharmacologic heparin binds to platelets augmenting formation of PF4 complexes. Boosting of preformed B cells by PF4\/heparin complexes could explain the early occurrence of IgG antibodies in HIT. We also found a continuous, rather than dichotomous, distribution of anti-PF4\/heparin IgM and IgG serum concentrations in a cross-sectional population study (n = 4029), indicating frequent preimmunization to modified PF4. PF4 may have a role in bacterial defense, and HIT is probably a misdirected antibacterial host defense mechanism.<\/jats:p>","DOI":"10.1182\/blood-2010-08-301424","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T23:47:21Z","timestamp":1287532041000},"page":"1370-1378","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":230,"title":["Platelet factor 4 binds to bacteria, inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia"],"prefix":"10.1182","volume":"117","author":[{"given":"Krystin","family":"Krauel","sequence":"first","affiliation":[{"name":"Institut f\u00fcr Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"P\u00f6tschke","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Weber","sequence":"additional","affiliation":[{"name":"Genetik der Mikroorganismen, Interfakult\u00e4res Institut f\u00fcr Genetik und Funktionelle Genomforschung, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Kessler","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Allgemeine Chirurgie, Viszeral-, Thorax- und Gef\u00e4sschirurgie, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitt","family":"F\u00fcrll","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Ittermann","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Community Medicine, Ernst-Moritz-Arndt-Universit\u00e4t, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Maier","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Allgemeine Chirurgie, Viszeral-, Thorax- und Gef\u00e4sschirurgie, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Hammerschmidt","sequence":"additional","affiliation":[{"name":"Genetik der Mikroorganismen, Interfakult\u00e4res Institut f\u00fcr Genetik und Funktionelle Genomforschung, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Br\u00f6ker","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Immunologie und Transfusionsmedizin, Ernst-Moritz-Arndt Universit\u00e4t, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111808380841700_B1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0268-960X(93)90024-X","article-title":"Platelet alpha-granules.","volume":"7","author":"Harrison","year":"1993","journal-title":"Blood Rev"},{"issue":"1","key":"2019111808380841700_B2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.thromres.2008.12.047","article-title":"Mechanism of low-molecular-weight heparin reversal by platelet factor 4.","volume":"124","author":"Fiore","year":"2009","journal-title":"Thromb Res"},{"issue":"3","key":"2019111808380841700_B3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-2004-831050","article-title":"Recombinant platelet factor 4 for heparin neutralization.","volume":"30","author":"Mixon","year":"2004","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2019111808380841700_B4","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"issue":"10","key":"2019111808380841700_B5","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2019111808380841700_B6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia 2.","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2019111808380841700_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus.","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb Haemost"},{"issue":"8","key":"2019111808380841700_B8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMcp052967","article-title":"Clinical practice: heparin-induced thrombocytopenia.","volume":"355","author":"Arepally","year":"2006","journal-title":"N Engl J Med"},{"issue":"20","key":"2019111808380841700_B9","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1182\/blood-2008-08-173062","article-title":"The temporal profile of the anti-PF4\/heparin immune response.","volume":"113","author":"Greinacher","year":"2009","journal-title":"Blood"},{"issue":"20","key":"2019111808380841700_B10","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2008-10-186064","article-title":"Studies of the immune response in heparin-induced thrombocytopenia.","volume":"113","author":"Warkentin","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111808380841700_B11","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2005-05-1824","article-title":"Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia.","volume":"106","author":"Greinacher","year":"2005","journal-title":"Blood"},{"issue":"19","key":"2019111808380841700_B12","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia.","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation"},{"issue":"5","key":"2019111808380841700_B13","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia.","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"issue":"1","key":"2019111808380841700_B14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11239-008-0217-y","article-title":"Platelet factor 4\/heparin antibody (IgG\/M\/A) in healthy subjects: a literature analysis of commercial immunoassay results.","volume":"26","author":"Arepally","year":"2008","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"2019111808380841700_B15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.","volume":"6","author":"Warkentin","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2019111808380841700_B16","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1538-7836.2008.03040.x","article-title":"Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of \u2018spontaneous\u2019 HIT?","volume":"6","author":"Jay","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111808380841700_B17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2008.03263.x","article-title":"Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery \u2018spontaneous\u2019 HIT.","volume":"7","author":"Pruthi","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111808380841700_B18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjmed.2008.03.012","article-title":"A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia.","volume":"121","author":"Warkentin","year":"2008","journal-title":"Am J Med"},{"issue":"5","key":"2019111808380841700_B19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-0038-1648491","article-title":"Heparin-associated thrombocytopenia: the antibody is not heparin specific.","volume":"67","author":"Greinacher","year":"1992","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111808380841700_B20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1055\/s-0038-1649842","article-title":"Characterization of the structural requirements for a carbohydrate based anticoagulant with a reduced risk of inducing the immunological type of heparin-associated thrombocytopenia.","volume":"74","author":"Greinacher","year":"1995","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111808380841700_B21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mlc.2001.115525","article-title":"Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia\/thrombosis.","volume":"138","author":"Visentin","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"2","key":"2019111808380841700_B22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2141.1992.tb08216.x","article-title":"Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan.","volume":"81","author":"Greinacher","year":"1992","journal-title":"Br J Haematol"},{"issue":"16","key":"2019111808380841700_B23","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1128\/JB.181.16.4725-4733.1999","article-title":"Structures of gram-negative cell walls and their derived membrane vesicles.","volume":"181","author":"Beveridge","year":"1999","journal-title":"J Bacteriol"},{"issue":"4","key":"2019111808380841700_B24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/MMBR.67.4.686-723.2003","article-title":"A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria.","volume":"67","author":"Neuhaus","year":"2003","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"2019111808380841700_B25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1046\/j.1365-2958.2002.03222.x","article-title":"Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells.","volume":"46","author":"Unkmeir","year":"2002","journal-title":"Mol Microbiol"},{"issue":"5","key":"2019111808380841700_B26","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/IAI.73.5.2680-2689.2005","article-title":"PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation.","volume":"73","author":"Pracht","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"2019111808380841700_B27","first-page":"323","article-title":"Differential expression of Listeria monocytogenes virulence genes in mammalian host cells.","volume":"261","author":"Bubert","year":"1999","journal-title":"Mol Gen Genet"},{"issue":"12","key":"2019111808380841700_B28","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1096\/fj.06-7992com","article-title":"Thrombospondin-1 promotes cellular adherence of gram-positive pathogens via recognition of peptidoglycan.","volume":"21","author":"Rennemeier","year":"2007","journal-title":"FASEB J"},{"issue":"2","key":"2019111808380841700_B29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0037-1615190","article-title":"Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid.","volume":"80","author":"Newman","year":"1998","journal-title":"Thromb Haemost"},{"issue":"12","key":"2019111808380841700_B30","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/j.1538-7836.2008.03171.x","article-title":"Heparin-induced thrombocytopenia: therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.","volume":"6","author":"Krauel","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111808380841700_B31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0609.2005.00621.x","article-title":"Incidence and clinical significance of anti-PF4\/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.","volume":"76","author":"Juhl","year":"2006","journal-title":"Eur J Haematol"},{"key":"2019111808380841700_B32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/9781420045093.010","article-title":"Laboratory testing for heparin-induced thrombocytopenia.","volume-title":"Heparin-induced Thrombocytopenia","author":"Warkentin","year":"2007"},{"issue":"6","key":"2019111808380841700_B33","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies.","volume":"70","author":"Kiefel","year":"1987","journal-title":"Blood"},{"issue":"6","key":"2019111808380841700_B34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.shk.0000126906.52367.dd","article-title":"Cecal ligation and puncture versus colon ascendens stent peritonitis: two distinct animal models for polymicrobial sepsis.","volume":"21","author":"Maier","year":"2004","journal-title":"Shock"},{"issue":"5","key":"2019111808380841700_B35","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/IAI.66.5.2300-2309.1998","article-title":"Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.","volume":"66","author":"Zantl","year":"1998","journal-title":"Infect Immun"},{"issue":"3","key":"2019111808380841700_B36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF01324255","article-title":"Study of Health In Pomerania (SHIP). A health examination survey in an East German region: objectives and design.","volume":"46","author":"John","year":"2001","journal-title":"Soz Praventivmed"},{"key":"2019111808380841700_B37","article-title":"Cohort profile: the study of health in Pomerania [published online ahead of print, February 18, 2010].","author":"Volzke","journal-title":"Int J Epidemiol"},{"issue":"17","key":"2019111808380841700_B38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia.","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111808380841700_B39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.1997.4183225.x","article-title":"Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.","volume":"99","author":"Pouplard","year":"1997","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111808380841700_B40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia.","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"issue":"4","key":"2019111808380841700_B41","first-page":"678","article-title":"Anti-heparin\/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.","volume":"100","author":"Whitlatch","year":"2008","journal-title":"Thromb Haemost"},{"issue":"6","key":"2019111808380841700_B42","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","article-title":"Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.","volume":"107","author":"Rauova","year":"2006","journal-title":"Blood"},{"key":"2019111808380841700_B43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/9781420045093.007","article-title":"Role of sulfated polysaccharides in the pathogenesis of heparin-induced thrombocytopenia.","volume-title":"Heparin-induced Thrombocytopenia","author":"Alban","year":"2007"},{"issue":"6","key":"2019111808380841700_B44","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"issue":"1","key":"2019111808380841700_B45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1537-2995.2009.02360.x","article-title":"Studies of the anti-platelet factor 4\/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.","volume":"50","author":"Selleng","year":"2010","journal-title":"Transfusion"},{"issue":"6","key":"2019111808380841700_B46","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2007-03-081901","article-title":"Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge.","volume":"110","author":"Kowalska","year":"2007","journal-title":"Blood"},{"issue":"8","key":"2019111808380841700_B47","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA.","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"issue":"4","key":"2019111808380841700_B48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2141.1993.tb03150.x","article-title":"Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides.","volume":"84","author":"Greinacher","year":"1993","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111808380841700_B49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0049-3848(88)90057-6","article-title":"Heparin binding to normal and abnormal platelets.","volume":"51","author":"Horne","year":"1988","journal-title":"Thromb Res"},{"issue":"1","key":"2019111808380841700_B50","first-page":"238","article-title":"Heparin binding to resting and activated platelets.","volume":"74","author":"Horne","year":"1989","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/4\/1370\/1340624\/zh800411001370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/4\/1370\/1340624\/zh800411001370.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T22:12:09Z","timestamp":1591999929000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/117\/4\/1370\/28566\/Platelet-factor-4-binds-to-bacteria-inducing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,27]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,1,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2010-08-301424","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.9384959.10016058","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,27]]}}}